Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x100px
Organisation › Details

Biotage AB (Nasdaq OMX Stockholm: BIOT.ST)

Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, pharmaceutical companies and food manufacturers, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan, South Korea and India. Biotage has approx. 405 employees and had sales of 911 MSEK in 2018. Biotage is listed on NASDAQ Stockholm. *


Period Start 2003-12-01 renamed
  Group Biotage (Group)
  Predecessor Pyrosequencing AB
Products Industry BIOTECH
  Industry 2 laboratory equipment and instruments
Persons Person Blomquist, Tomas (Biotage 201911– CEO before Abbott EMEA + Alere + Analyticon + JnJ + Roche)
  Person 2 Eklund, Thomas (Investor Growth Capital + Alfred Berg ABN AMRO Capital Investment + Handelsbanken)
Region Region Uppsala
  Country Sweden
  Street 76 Kungsgatan
  City 753 18 Uppsala
  Tel +46-18-565900
    Address record changed: 2020-12-02
Basic data Employees D: 101 to 500 (2014-12-31)
  Currency SEK
  Annual sales 911,000,000 (sales, consolidated (2018) 2018-12-31)
    * Document for »About Section«: Biotage AB. (6/4/19). "Press Release: Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications". Uppsala.
Record changed: 2023-07-10


Picture EBD Group ChinaBio Partnering Forum 2023 Shanghai 650x200px

More documents for Biotage (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x300px

» top